To evaluate potential pharmacodynamic interactions between TPCs and glucocorticoids, a mainstay of AD treatment, we investigated the effect of the concomitant administration of TPCs and glucocorticoids in mice with MOG-induced EAE. The gene discussed is MOG; the disease is Alzheimer disease.